Balance Sheet

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Fulgent Genetics (FLGT) Cash from Discontinued Operations (2016)

Fulgent Genetics (FLGT) has disclosed Cash from Discontinued Operations for 2 consecutive years, with 14000.0 as the latest value for Q2 2016.

Quarterly Cash from Discontinued Operations changed N/A to 14000.0 in Q2 2016 from the year-ago period, while the trailing twelve-month figure was 31000.0 through Dec 2016, changed N/A year-over-year, with the annual reading at 31000.0 for FY2016, 98.96% up from the prior year.
Cash from Discontinued Operations hit 14000.0 in Q2 2016 for Fulgent Genetics, up from 17000.0 in the prior quarter.
In the past five years, Cash from Discontinued Operations ranged from a high of 14000.0 in Q2 2016 to a low of 916000.0 in Q4 2015.